Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from delta9-tetrahydrocannabinol in C57BL/6 mice

Neuroscience Letters

Volumn 465, Issue 1, 2009, Pages 66-70

  Huang, Peng ^a   Liu Chen, Lee Yuan ^a   Unterwald, Ellen M ^a   Cowan, Alan ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Abstinence; Locomotion; Mice; SR141716; THC; Withdrawal

Indexed keywords

DRONABINOL; RIMONABANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; LIMB TREMOR; LOCOMOTION; MALE; MOBILIZATION; MORNING DOSAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESPONSE TIME; SCRATCHING; STEREOTYPY; WITHDRAWAL SYNDROME;

ANALYSIS OF VARIANCE; ANIMALS; DYSKINESIA, DRUG-INDUCED; FORELIMB; LOCOMOTION; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; PIPERIDINES; PSYCHOTROPIC DRUGS; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; SUBSTANCE WITHDRAWAL SYNDROME; TETRAHYDROCANNABINOL; TREMOR;

EID: 70349109586     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.08.073     Document Type: Article

References (17)

1. Adams I.B., and Martin B.R. Cannabis: pharmacology and toxicology in animals and humans. Addiction 91 (1996) 1585-1614
2. Bass C.E., Griffin G., Grier M., Mahadevan A., Razdan R.K., and Martin B.R. SR-141716A-induced stimulation of locomotor activity. A structure-activity relationship study. Pharmacol. Biochem. Behav. 74 (2002) 31-40
3. Compton D.R., Aceto M.D., Lowe J., and Martin B.R. In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J. Pharmacol. Exp. Ther. 277 (1996) 586-594
4. Cook S.A., Lowe J.A., and Martin B.R. CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 285 (1998) 1150-1156
5. Cooper Z.D., and Haney M. Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor. Addict. Biol. 13 (2008) 188-195
6. Hutcheson D.M., Tzavara E.T., Smadja C., Valjent E., Roques B.P., Hanoune J., and Maldonado R. Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol. Br. J. Pharmacol. 125 (1998) 1567-1577
7. Lichtman A.H., Fisher J., and Martin B.R. Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine. Pharmacol. Biochem. Behav. 69 (2001) 181-188
8. Lichtman A.H., and Martin B.R. Marijuana withdrawal syndrome in the animal model. J. Clin. Pharmacol. 42 (2002) 20S-27S
9. Lichtman A.H., Sheikh S.M., Loh H.H., and Martin B.R. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice. J. Pharmacol. Exp. Ther. 298 (2001) 1007-1014
10. Maldonado R. Study of cannabinoid dependence in animals. Pharmacol. Ther. 95 (2002) 153-164
11. McMahon L.R., and Koek W. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice. Eur. J. Pharmacol. 569 (2007) 70-76
12. Oliva J.M., Ortiz S., Palomo T., and Manzanares J. Behavioural and gene transcription alterations induced by spontaneous cannabinoid withdrawal in mice. J. Neurochem. 85 (2003) 94-104
13. Schlosburg J.E., Boger D.L., Cravatt B.F., and Lichtman A.H. Endocannabinoid modulation of scratching response in an acute allergenic model: a new prospective neural therapeutic target for pruritus. J. Pharmacol. Exp. Ther. 329 (2009) 314-323
14. Seong E., Saunders T.L., Stewart C.L., and Burmeister M. To knockout in 129 or in C57BL/6: that is the question. Trends Genet. 20 (2004) 59-62
15. Tourino C., Maldonado R., and Valverde O. MDMA attenuates THC withdrawal syndrome in mice. Psychopharmacology (Berl.) 193 (2007) 75-84
16. Tsou K., Patrick S.L., and Walker J.M. Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist. Eur. J. Pharmacol. 280 (1995) R13-R15
17. Wilson D.M., Varvel S.A., Harloe J.P., Martin B.R., and Lichtman A.H. SR 141716 (Rimonabant) precipitates withdrawal in marijuana-dependent mice. Pharmacol. Biochem. Behav. 85 (2006) 105-113